Barbosa, R., Jawa, R., Watters, J., Knight, J., Kerwin, A., Winston, E., & ... Rowell, S. (2012). Evaluation and management of mild traumatic brain injury: an Eastern Association for the Surgery of Trauma practice management guideline. The Journal Of Trauma And Acute Care Surgery, 73(5 Suppl 4), S307-S314. doi:10.1097/TA.0b013e3182701885
Evaluation and Management of Mild Traumatic Brain Injury: an Eastern Association for the Surgery of Trauma Practice Management GuidelineThe Journal Of Trauma And Acute Care Surgery
AbstractBACKGROUND: An estimated 1.1 million people sustain a mild traumatic brain injury (MTBI) annually in the United States. The natural history of MTBI remains poorly characterized, and its optimal clinical management is unclear. The Eastern Association for the Surgery of Trauma had previously published a set of practice management guidelines for MTBI in 2001. The purpose of this review was to update these guidelines to reflect the literature published since that time. METHODS: The PubMed and Cochrane Library databases were searched for articles related to MTBI published between 1998 and 2011. Selected older references were also examined. RESULTS: A total of 112 articles were reviewed and used to construct a series of recommendations. CONCLUSION: The previous recommendation that brain computed tomographic (CT) should be performed on patients that present acutely with suspected brain trauma remains unchanged. A number of additional recommendations were added. Standardized criteria that may be used to determine which patients receive a brain CT in resource-limited environments are described. Patients with an MTBI and negative brain CT result may be discharged from the emergency department if they have no other injuries or issues requiring admission. Patients taking warfarin who present with an MTBI should have their international normalized ratio (INR) level determined, and those with supratherapeutic INR values should be admitted for observation. Deficits in cognition and memory usually resolve within 1 month but may persist for longer periods in 20% to 40% of cases. Routine use of magnetic resonance imaging, positron emission tomography, nuclear magnetic resonance, or biochemical markers for the clinical management of MTBI is not supported at the present time.
Peer Reviewed for front end displayPeer-Reviewed